• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者伴危险因素的细胞因子超级风暴:BCG 免疫接种的治疗潜力。

A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.

机构信息

Female Reproduction and Metabolic Syndromes Laboratory, Division of Molecular Reproduction, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695 014, Kerala, India; Research Centre Kerala University, Senate House Campus, Palayam, Thiruvananthapuram, India.

Female Reproduction and Metabolic Syndromes Laboratory, Division of Molecular Reproduction, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695 014, Kerala, India.

出版信息

Cytokine Growth Factor Rev. 2020 Aug;54:32-42. doi: 10.1016/j.cytogfr.2020.06.014. Epub 2020 Jul 1.

DOI:10.1016/j.cytogfr.2020.06.014
PMID:32747157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7328575/
Abstract

The seventh human coronavirus SARS-CoV2 belongs to the cluster of extremely pathogenic coronaviruses including SARS-CoV and MERS-CoV, which can cause fatal lower respiratory tract infection. Likewise, SARS-CoV2 infection can be fatal as the disease advances to pneumonia, followed by acute respiratory distress syndrome (ARDS). The development of lethal clinical symptons is associated with an exaggerated production of inflammatory cytokines, referred to as the cytokine storm, is a consequence of a hyperactivated immune response aginst the infection. In this article, we discuss the pathogenic consequences of the cytokine storm and its relationship with COVID-19 associated risk factors. The increased pro-inflammatory immune status in patients with risk factors (diabetes, hypertension, cardiovascular disease, COPD) exacerbates the Cytokine-storm of COVID-19 into a 'Cytokine Super Cyclone'. We also evaluate the antiviral immune responses provided by BCG vaccination and the potential role of 'trained immunity' in early protection against SARS-CoV2.

摘要

第七种人类冠状病毒 SARS-CoV2 属于包括 SARS-CoV 和 MERS-CoV 在内的高致病性冠状病毒群,可导致致命的下呼吸道感染。同样,随着疾病进展为肺炎,随后发展为急性呼吸窘迫综合征(ARDS),SARS-CoV2 感染可能是致命的。致命临床症状的发展与炎症细胞因子的过度产生有关,称为细胞因子风暴,是针对感染的过度激活免疫反应的结果。在本文中,我们讨论了细胞因子风暴的发病后果及其与 COVID-19 相关危险因素的关系。具有危险因素(糖尿病、高血压、心血管疾病、COPD)的患者促炎免疫状态增加,使 COVID-19 的细胞因子风暴加剧为“细胞因子超级旋风”。我们还评估了卡介苗接种提供的抗病毒免疫反应以及“训练免疫”在早期预防 SARS-CoV2 中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/19a7e44fbe85/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/698547c4536d/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/b9f3d0a0e968/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/7b87f37803b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/19a7e44fbe85/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/698547c4536d/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/b9f3d0a0e968/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/7b87f37803b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57e/7328575/19a7e44fbe85/gr3_lrg.jpg

相似文献

1
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.COVID-19 患者伴危险因素的细胞因子超级风暴:BCG 免疫接种的治疗潜力。
Cytokine Growth Factor Rev. 2020 Aug;54:32-42. doi: 10.1016/j.cytogfr.2020.06.014. Epub 2020 Jul 1.
2
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
3
Lessons for COVID-19 Immunity from Other Coronavirus Infections.其他冠状病毒感染带来的 COVID-19 免疫经验教训。
Immunity. 2020 Aug 18;53(2):248-263. doi: 10.1016/j.immuni.2020.07.005. Epub 2020 Jul 14.
4
Severe COVID-19: what have we learned with the immunopathogenesis?严重的 COVID-19:我们从免疫发病机制中学到了什么?
Adv Rheumatol. 2020 Sep 22;60(1):50. doi: 10.1186/s42358-020-00151-7.
5
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?炎症消退:避免 COVID-19 中细胞因子风暴的双管齐下策略?
Cancer Metastasis Rev. 2020 Jun;39(2):337-340. doi: 10.1007/s10555-020-09889-4.
6
Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.对 SARS-CoV、MERS-CoV 和 SARS-CoV-2 的免疫反应。
Adv Exp Med Biol. 2020;1288:5-12. doi: 10.1007/5584_2020_549.
7
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.冠状病毒诱导的急性呼吸窘迫综合征(ARDS)的免疫发病机制:潜在的感染相关性噬血细胞性淋巴组织细胞增多症。
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00074-20.
8
Cytokine storm intervention in the early stages of COVID-19 pneumonia.COVID-19 肺炎早期的细胞因子风暴干预。
Cytokine Growth Factor Rev. 2020 Jun;53:38-42. doi: 10.1016/j.cytogfr.2020.04.002. Epub 2020 Apr 25.
9
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.通过对固有免疫的控制调节来预防和治疗 COVID-19 疾病。
Eur J Immunol. 2020 Jul;50(7):932-938. doi: 10.1002/eji.202048693. Epub 2020 Jun 15.
10
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.SARS-CoV、MERS-CoV 和 SARS-CoV-2 冠状病毒感染的比较免疫学特征。
Front Immunol. 2020 Aug 14;11:2033. doi: 10.3389/fimmu.2020.02033. eCollection 2020.

引用本文的文献

1
Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome.COVID-19 期间细胞因子趋势的前瞻性变化:从发病到结局的递进方法。
Int J Mol Sci. 2024 Oct 1;25(19):10578. doi: 10.3390/ijms251910578.
2
Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies.糖尿病与新冠病毒易感性:风险因素及预防和治疗策略
World J Diabetes. 2024 Aug 15;15(8):1663-1671. doi: 10.4239/wjd.v15.i8.1663.
3
Improving outcomes in co-morbid diabetes and COVID-19: A quasi-experimental study.

本文引用的文献

1
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号,导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
2
Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis.卡介苗接种覆盖率较高国家的新冠疫情结果显著改善:一项多变量分析
Vaccines (Basel). 2020 Jul 11;8(3):378. doi: 10.3390/vaccines8030378.
3
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
改善合并糖尿病和 COVID-19 患者的结局:一项准实验研究。
S Afr Fam Pract (2004). 2023 Feb 13;65(1):e1-e10. doi: 10.4102/safp.v65i1.5631.
4
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?从细胞因子风暴到细胞因子微风:免疫发病机制的经验教训是否改善了中重度新冠肺炎的免疫调节治疗?
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
5
Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health.肠道微生物群和宿主基因调控不同饮食模式对代谢健康的影响。
Front Nutr. 2022 Aug 18;9:896348. doi: 10.3389/fnut.2022.896348. eCollection 2022.
6
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine.针对 2019 年冠状病毒病(COVID-19)的靶向治疗:从细胞和基因治疗到免疫治疗和疫苗的启示。
Int Immunopharmacol. 2022 Oct;111:109161. doi: 10.1016/j.intimp.2022.109161. Epub 2022 Aug 18.
7
Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq.伊拉克库尔德斯坦地区埃尔比勒 300 例 COVID-19 患者的临床和血液学特征。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221085465. doi: 10.1177/03946320221085465.
8
Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p.高度保守的 SARS-CoV-2 s2m 元件通过亲吻复合物二聚化,并与宿主 miRNA-1307-3p 相互作用。
Nucleic Acids Res. 2022 Jan 25;50(2):1017-1032. doi: 10.1093/nar/gkab1226.
9
Cancer and Covid-19: Collectively catastrophic.癌症与新冠疫情:双重灾难。
Cytokine Growth Factor Rev. 2022 Feb;63:78-89. doi: 10.1016/j.cytogfr.2021.10.005. Epub 2021 Oct 23.
10
On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers.新冠患者细胞与严重程度标志物的深度景观探索
Front Immunol. 2021 Sep 16;12:705646. doi: 10.3389/fimmu.2021.705646. eCollection 2021.
严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
4
Interferon-α2b Treatment for COVID-19.干扰素-α2b 治疗 COVID-19。
Front Immunol. 2020 May 15;11:1061. doi: 10.3389/fimmu.2020.01061. eCollection 2020.
5
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学:科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
6
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.炎症小体和细胞焦亡作为 COVID-19 的治疗靶点。
J Immunol. 2020 Jul 15;205(2):307-312. doi: 10.4049/jimmunol.2000513. Epub 2020 Jun 3.
7
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.COVID-19 中的细胞因子风暴:趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
8
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
9
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.糖尿病与2019冠状病毒病的死亡率及严重程度相关吗?一项荟萃分析。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):535-545. doi: 10.1016/j.dsx.2020.04.044. Epub 2020 May 6.
10
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫:能提供针对 COVID-19 的保护吗?
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.